切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (11) : 872 -876. doi: 10.3877/cma.j.issn.1674-0785.2019.11.016

所属专题: 文献

综述

精神药物的甲状腺不良反应
孙振晓1,(), 于相芬1   
  1. 1. 276005 山东省临沂市精神卫生中心精神科
  • 收稿日期:2019-05-01 出版日期:2019-06-01
  • 通信作者: 孙振晓

Thyroid side effects of psychotropic drugs

Zhenxiao Sun1,(), Xiangfen Yu1   

  1. 1. Department of Psychiatry, Linyi Municipal Mental Health Center, Linyi 276005, China
  • Received:2019-05-01 Published:2019-06-01
  • Corresponding author: Zhenxiao Sun
  • About author:
    Corresponding author: Sun Zhenxiao, Email:
引用本文:

孙振晓, 于相芬. 精神药物的甲状腺不良反应[J]. 中华临床医师杂志(电子版), 2019, 13(11): 872-876.

Zhenxiao Sun, Xiangfen Yu. Thyroid side effects of psychotropic drugs[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(11): 872-876.

许多精神药物可通过干扰甲状腺激素合成的多个环节影响甲状腺的生理功能。本文旨在对精神药物的甲状腺不良反应作一综述。

Many psychotropic drugs can affect the physiological function of the thyroid gland by interfering with thyroid hormone synthesis at multiple levels. This article reviews the thyroid adverse reactions of psychotropic drugs.

1
Bou Khalil R, Richa S. Thyroid adverse effects of psychotropic drugs: a review [J]. Clin Neuropharmacol, 2011, 34(6): 248-255.
2
Samuels MH. Psychiatric and cognitive manifestations of hypothyroidism [J]. Curr Opin Endocrinol Diabetes Obes, 2014, 21(5): 377-383.
3
Feldman AZ, Shrestha RT, Hennessey JV. Neuropsychiatric manifestations of thyroid disease [J]. Endocrinol Metab Clin North Am, 2013, 42(3): 453-476.
4
汪旭, 王丽, 裴敏, 等. 长期服用抗精神药物对精神分裂症患者甲状腺和肝脏的影响 [J].国际精神病学杂志, 2018, 45(3): 456-458.
5
Vedal TSJ, Steen NE, Birkeland KI, et al. Free thyroxine and thyroid-stimulating hormone in severe mental disorders: a naturalistic study with focus on antipsychotic medication [J]. J Psychiatr Res, 2018, 106: 74-81.
6
Bunevicius R, Steibliene V, Prange AJ Jr. Thyroidaxisfunctionafter in-patient treatment of acute psychosis with antipsychotics: a naturalistic study [J]. BMC Psychiatry, 2014, 14: 279.
7
Gründer G, Wetzel H, Schlösser R, et al. Neuroendocrine response to antipsychotics:effects of drug type and gender [J]. Biol Psychiatry, 1999, 45(1): 89-97.
8
Paunović VR, Timotijević I, Marinković D. Neuroleptic actions on the thyroid axis: different effects of clozapine and haloperidol [J]. Int Clin Psychopharmacol, 1991, 6(3): 133-139.
9
Kelly DL, Conley RR. Neuroleptic actions on the thyroid axis: different effects of clozapine and haloperidol [J]. J Clin Psychiatry, 2005, 66(1): 80-84.
10
Feret BM, Caley CF. Possible hypothyroidism associated with quetiapine [J]. Ann Pharmacother, 2000, 34(4): 483-486.
11
Park YM, Kang SG, Lee BH, et al. Decreased thyroid function in Korean women with bipolar disorder receiving valproic acid [J]. Gen Hos Psychiatry, 2011, 33: 200.e13-200.e15.
12
Poyraz BC, Aksoy C, Balcioğlu I. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia [J]. Eur Neuropsycho-pharmacol, 2008, 18(9): 667-672.
13
Ohta H, Inoue S, Hara K, et al. TSH and PRL, side-effect markers in aripiprazole treatment: adjunctive aripiprazole-induced thyrotropin oversuppression in a young man with schizophrenia [J]. BMJ Case Rep, 2017, Aug 22.
14
Shelton RC, Winn S, Ekhatore N, et al. The effects of antidepressants on the thyroidaxis in depression [J]. Biol Psychiatry, 1993, 33(2): 120-126.
15
Gitlin M, Altshuler LL, Frye MA, et al. Peripheralthyroid hormones and response to selective serotonin reuptake inhibitors [J]. J Psychiatry Neurosci, 2004, 29(5): 383-386.
16
König F, Hauger B, von Hippel C, et al. Effect of paroxetine on thyroid hormone levels in severely depressed patients [J]. Neuropsychobiology, 2000, 42(3): 135-138.
17
Shelton RC, Winn S, Ekhatore N, et al. The effects of antidepressants on the thyroid axis in depression [J]. Biol Psychiatry, 1993, 33(2): 120-126.
18
de Carvalho GA, Bahls SC, Boeving A, et al. Effectsofselective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function [J]. Thyroid, 2009, 19(7): 691-697.
19
Gambi F, De Berardis D, Sepede G, et al. Effect of mirtazapine on thyroid hormones in adult patients with major depression [J]. Int J Immunopathol Pharmacol, 2005, 18(4): 737-744.
20
Eker SS, Akkaya C, Sarandol A, et al. Effectsof various antidepressants on serum thyroid hormone levels in patients with major depressive disorder [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32(4): 955-961.
21
Fagiolini A, Kupfer DJ, Scott J, et al. Hypothyroidism in patients with bipolar Ⅰ disorder treated primarily with lithium [J]. Epidemiol Psichiatr Soc, 2006, 15(2): 123-127.
22
Kirov G, Tredger J, John R, et al. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients [J]. J Affective Disorder, 2005, 87: 313-317.
23
Kraszewska A, Chlopocka-Wozniak M, Abramowicz M, et al. A cross-sectional study of thyroid functionin 66 patients with bipolar disorder receiving lithium for 10-44 years [J]. Bipolar Disord, 2015, 17(4): 375-380.
24
Sethy RR, Sinha VK. Effect of lithium on thyroid function in adolescents with mood disorder [J]. Asian J Psychiatr, 2016, 24: 41-45.
25
Miller KK, Dnniels GH. Association between lithium use and thyrotoxicosic caused silent thyroiditis [J]. Clin Endocrinol, 2001, 55(4): 501-508.
26
Isojärvi JI, Turkka J, Pakarinen AJ, et al. Thyroid functions in men taking carbamazepine, oxcarbazepine or valproate for epilepsy [J]. Epilepsia, 2001, 42(7): 930-934.
27
Simko J, Horacek J. Carbamazepine and risk of hypo-thyroidism: a prospective study [J]. Acta Neurol Scand, 2007, 116(5): 317-321.
28
Curan PG, DeGroot LI. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland [J]. Endocr Rev, 1991, 12(2): 135-150.
29
Mikati MA, Tarabuy H, Khalil A, et al. Risk factors for development of subclinical hypothyroidism during valproic acid therapy [J]. J Pediatr, 2007, 151: 178-181.
30
Park YM, Kang SG, Lee BH, et al. Decreased thyroid function in Korean women with bipolar disorder receiving valproic acid [J]. Gen Hos Psychiatry, 2011, 33: 200.e13-200.e15.
[1] 王青青, 耿翠芝, 苏晓雨, 彭玉晓, 秦明祎, 刘风侠. 乳腺癌芳香化酶抑制剂相关肌肉骨骼不良反应的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 243-249.
[2] 丁璐月, 刘炜, 魏昂, 张瑞东, 王天有, 刘霖霖, 臧博伦, 王亚峰, 郭明发. 贝林妥欧单抗治疗儿童复发/难治CD19+急性B淋巴细胞白血病临床观察[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 194-201.
[3] 李志伟, 向琪, 彭胜男, 郭玲, 孙贱根, 杨川. 右美托咪定与曲马多分别复合罗哌卡因在全麻下结肠癌根治术中的应用[J]. 中华普通外科学文献(电子版), 2023, 17(03): 182-185.
[4] 陈滔, 罗洪, 周进军. 老年食管癌单纯放疗及同期放化疗患者急性不良反应影响因素分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 405-407.
[5] 季媛, 魏巴金. NLRP3炎性小体在器官移植不良反应发病机制中的研究进展[J]. 中华移植杂志(电子版), 2023, 17(05): 308-312.
[6] 陈瑜, 尤良顺, 孟海涛, 杨敏. 嵌合抗原受体T细胞治疗多发性骨髓瘤新进展[J]. 中华移植杂志(电子版), 2023, 17(05): 313-320.
[7] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[8] 姜里蛟, 张峰, 周玉萍. 多学科诊疗模式救治老年急性非静脉曲张性上消化道大出血患者的临床观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 520-524.
[9] 盛静, 梅勇, 夏佩, 王晓林. 乌苯美司联合伊立替康二线治疗晚期胃癌的临床研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 317-321.
[10] 徐洪宇, 何亚爽. 羟考酮与氢吗啡酮用于胃癌根治术后镇痛的疗效[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 312-316.
[11] 于晓东, 李德华, 高山, 徐鑫. 理中汤加味联合美沙拉嗪治疗轻度活动期克罗恩病的临床观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 199-202.
[12] 董骏, 吴芳芳. mFOLFOX6与FOLFOX4化疗方案治疗直肠癌的临床疗效及安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 236-240.
[13] 王昊, 明倩文, 王斌, 卢太坤, 张海宁. 利奈唑胺致黑毛舌的临床诊断学特征[J]. 中华诊断学电子杂志, 2023, 11(04): 254-260.
[14] 廖安琪, 王玫, 廖远泉. 达格列净诱发糖尿病患者血尿发生的临床诊断特征[J]. 中华诊断学电子杂志, 2023, 11(03): 169-172.
[15] 何亚伟, 陈皖京, 宋佳宏, 于刚, 贾犇黎, 汪泳. 肥胖患者SCH、血清维生素D水平与NAFLD严重程度关系的研究[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 95-101.
阅读次数
全文


摘要